Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice
By combining three powerful mechanisms in one therapy, it demonstrates how multi-receptor peptides can deliver broader, more durable results than ever before
Powder offers higher, flexible dosing, but it is bitter and easy to skip
Serious but uncommon risks include acute pancreatitis, gallbladder disease, and dehydration, requiring prompt medical attention if symptoms develop
Youll notice the fat around the treatment area will start getting softer
Cardiovascular Outcomes# EXSCEL Trial (Exenatide)# The EXSCEL trial (Holman et al., NEJM 2017) enrolled 14,752 patients with type 2 diabetes (73.1% with prior cardiovascular disease) and followed them for a median of 3.2 years: Primary MACE endpoint : HR 0.91 (95% CI 0.83-1.00), p=0.06 for superiority Met non-inferiority but narrowly missed superiority (p=0.06) All-cause mortality was reduced by 14% (HR 0.86, p=0.016) in a secondary analysis EXSCEL confirmed cardiovascular safety but did not prove cardiovascular benefit -- a critical distinction